Meriwether Wealth & Planning
ABBV icon

Meriwether Wealth & Planning’s AbbVie ABBV Stock Holding History

Meriwether Wealth & Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$652K Buy
2,493
+55
+2% +$14.1K 0.29% 57
2026
Q2 		$613K Sell
2,438
-29
-1% -$6.24K 0.3% 58
2026
Q1 		$537K Sell
2,467
-99
-4% -$22K 0.29% 57
2025
Q4 		$586K Sell
2,566
-211
-8% -$48.1K 0.33% 60
2025
Q3 		$643K Sell
2,777
-112
-4% -$22.8K 0.37% 51
2025
Q2 		$536K Sell
2,889
-56
-2% -$10.4K 0.34% 57
2025
Q1 		$617K Buy
2,945
+5
+0.2% +$972 0.4% 52
2024
Q4 		$522K Buy
+2,940
New +$541K 0.37% 55

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Meriwether Wealth & Planning's ABBV Position: Q3 2026 in Review

Meriwether Wealth & Planning increased its AbbVie (ABBV) stake by 2.3% in Q3 2026, buying an estimated $14.1K and bringing the position to 2,493 shares worth $652K. The position accounts for 0.29% of the portfolio, ranked #57.

Meriwether Wealth & Planning first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,321 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Meriwether Wealth & Planning held 2,493 shares of AbbVie worth $652K as of Q3 2026.
  • Meriwether Wealth & Planning bought 55 AbbVie shares in Q3 2026, an estimated $14.1K.
  • AbbVie made up 0.29% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #57 holding.
  • Meriwether Wealth & Planning first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,321 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.